Prism Medico and Pharmacy Limited Stock

Equities

PRISMMEDI6

INE730E01016

Fishing & Farming

Delayed Bombay S.E. 01:00:33 2024-04-19 am EDT 5-day change 1st Jan Change
24.99 INR 0.00% Intraday chart for Prism Medico and Pharmacy Limited -1.69% -18.12%
Sales 2022 84.44M 1.01M Sales 2023 12.71M 152K Capitalization 174M 2.08M
Net income 2022 -3M -35.93K Net income 2023 - 0 EV / Sales 2022 0.54 x
Net cash position 2022 551K 6.6K Net cash position 2023 957K 11.47K EV / Sales 2023 13.6 x
P/E ratio 2022
-12.5 x
P/E ratio 2023
-220 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 59%
More Fundamentals * Assessed data
Dynamic Chart
Prism Medico and Pharmacy Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Prism Medico and Pharmacy Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Prism Medico and Pharmacy Limited Approves to Regularize the Appointment of Dinesh Kumar as A Director (Non-Executive, Independent Director) CI
Prism Medico and Pharmacy Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Prism Medico and Pharmacy Limited Announces the Appointment of Mr. Vishwambhar Dayal Gupta as Director CI
Prism Medico and Pharmacy Limited Appoints Sakshi Laller as A Whole Time Director (Promoter, Executive Director, Women Director) CI
Prism Medico Appoints CFO MT
Prism Medico's CFO Resigns MT
Symbiosis Pharmaceutical Services Limited, Galaxy Vitacare Private Limited, and Ramit Walia completed the acquisition of a 1.07% stake in Prism Medico and Pharmacy Limited for INR 0.71 million CI
Symbiosis Pharmaceutical Services Limited, Galaxy Vitacare Private Limited and Ramit Walia made an offer to acquire a 26% stake in Prism Medico and Pharmacy Limited from its shareholders for INR 17.34 million CI
Galaxy Vitacare Private Limited, Symbiosis Pharmaceutical Services Limited and Ramit Walia entered a share purchase agreement to acquire a 23.93% stake in Prism Medico and Pharmacy Limited from Ajooni Biotech Limited, Parmjeet Kaur, Jasjot Singh and Charanjit Singh Bhatia for INR 15.96 million. CI
Prism Medico and Pharmacy Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Prism Medico and Pharmacy Widens Net Loss in Fiscal Q1; Shares Drop 3% MT
Prism Medico and Pharmacy Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Prism Medico and Pharmacy Limited Announces Address Changes CI
More news
1 week-1.69%
Current month-8.39%
1 month-2.27%
3 months-22.00%
6 months-12.35%
Current year-18.12%
More quotes
1 week
24.12
Extreme 24.12
26.94
1 month
22.05
Extreme 22.05
29.70
Current year
22.05
Extreme 22.05
39.20
1 year
22.05
Extreme 22.05
39.20
3 years
4.56
Extreme 4.56
46.80
5 years
4.56
Extreme 4.56
46.80
10 years
4.56
Extreme 4.56
55.90
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 23-05-15
Compliance Officer 38 20-06-07
Members of the board TitleAgeSince
Director/Board Member - 21-12-29
Director/Board Member - 21-12-29
Director/Board Member - 23-05-15
More insiders
Date Price Change Volume
24-04-19 24.99 0.00% 721
24-04-18 24.99 -2.38% 15,355
24-04-16 25.6 +1.59% 2,150
24-04-15 25.2 -0.87% 3,637
24-04-12 25.42 +0.79% 5,122

Delayed Quote Bombay S.E., April 19, 2024 at 01:00 am EDT

More quotes
Prism Medico and Pharmacy Limited is an India-based company that is engaged in wholesaling and retailing of straw, fodder and other animal/poultry feed as well as its manufacturing, buying, dealing, export, importing, and trading. The Company acts as wholesaler, retailer, suppliers, selling agent, buying agent, repackers, analytical chemists, druggist, refiners, processors, merchants and stockiest for various types of chemicals, serums, chemical products, antibiotics, medicines, drugs, pharmaceuticals pesticide, dyes, soaps oil, perfumes, cosmetic, and patent medicine. The Company has not been able to carry out any operations. It is presently engaged in trading.
More about the company
  1. Stock Market
  2. Equities
  3. PRISMMEDI6 Stock